Yahoo Finance 
Global Small-scale Bioreactors Market Outlook 2024-2029 - Reusable Bioreactors Gaining Momentum due to Their Sustainable Advantage and Lifecycle Cost Benefits
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Small-scale Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's offering.
The global market for small-scale bioreactors, a pivotal component in biopharmaceutical manufacturing, has witnessed a valued projection at USD 1.52 billion in 2023. Expected to manifest a steady increase with a CAGR of 5.25% leading up to 2029, this market responds dynamically to the escalating demands for biopharmaceuticals and the continuous advancements in bioprocessing technology.
The vigorous growth of the biopharmaceutical industry, spurred by breakthroughs in biotechnology, and the rising pursuits of therapeutic innovations, contribute substantially to the expansion of the global small-scale bioreactors market. These bioreactors facilitate an efficient and economical pathway for developing and producing biological treatments, an upsurging demand endorsed by modern healthcare advancements. In parallel, personalized medicine's growing demand is propelling the market with tailor-made therapies predicated on individual patient profiles escalating the need for flexible and scalable bioreactor solutions.
Notwithstanding the promise of small-scale bioreactors, cost considerations and the complexity of regulatory compliance present as ongoing challenges. However, the industry counters these with significant technological enhancements in bioreactor systems, automation, and single-use technologies. Innovations in the sector allow for minimized costs, elevated flexibility, and the accelerated pace of bringing biopharmaceutical products to market.
On a sectoral level, reusable bioreactors are gaining momentum, thanks to their sustainable advantage and lifecycle cost benefits, hinting at a market shift towards eco-friendly production practices. The pharmaceutical and biopharmaceutical companies segment is also projected to see notable growth due to the relentless demand for biologics and the critical role small-scale bioreactors play in their development and production. Regionally, North America maintains its prominence in the market, supported by a robust innovation culture and the presence of numerous biopharmaceutical ventures.
The global small-scale bioreactors market stands at a juncture where technological advancements, sustainable practices, and the pressing need for personalized medicine are charting a steady course for growth. As the market continues to adapt to these dynamic demands, small-scale bioreactors remain at the forefront of bioprocessing innovation, aiding the biopharmaceutical industry in delivering the next generation of healthcare solutions.
A selection of companies mentioned in this report includes, but is not limited to:
Sartorius AG
Thermo Fisher Scientific Inc.
Merck KGaA
Danaher Corp.
Lonza Group Ltd.
Eppendorf SE
Miltenyi Biotec India Pvt. Ltd.
Getinge AB
Solaris Biotech USA, Inc.
Infors AG
For more information about this report visit https://www.researchandmarkets.com/r/d0curt
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
